Skip to main content
An official website of the United States government
Email

Symptom Management and Health-Related Quality of Life Steering Committee Roster

The Symptoms Management and Health-Related Quality of Life Steering Committee (SxQoLSC) addresses the design, prioritization, and evaluation of concepts for phase 2 and phase 3 clinical trials to control cancer symptoms and cancer treatment side effects. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The SxQoLSC's membership comprises representatives from the NCORP Research Bases, R01 investigators, community oncologists, biostatisticians, patient advocates, and NCI Staff.

 

Co-chairs

Michelle Janelsins, Ph.D., M.P.H.
University of Rochester Medical Center
Rochester, NY

Glenn Lesser, M.D.
Wake Forest University Comprehensive Cancer Center 
Winston-Salem, NC

 

Members

Erin O'Carroll Bantum, Ph.D.
University of Hawai'i Cancer Center
Honolulu, HI

Julienne Bower, Ph.D.
University of California, Los Angeles
Los Angeles, CA

David Cella, Ph.D.
Northwestern University
Chicago, IL

Winson Y. Cheung, M.D., M.P.H., FRCP
University of Calgary
Calgary, AB, Canada

Kimberly S. Corbin, M.D.
Mayo Clinic
Rochester, MN

Tracy E. Crane, Ph.D., RDN
University of Miami Sylvester Comprehensive Cancer Center 
Miami, FL

Emily Dressler, Ph.D. 
Wake Forest University School of Medicine
Winston-Salem, NC

Leanne Embry, Ph.D.
University of Texas Health Science Center at San Antonio
San Antonio, TX

Michael Fisch, M.D., M.P.H., FACP, FAAHPM, FASCO
AIM Specialty Health
Deerfield, IL

Marjorie J. Good, M.P.H., RN, OCN
National Cancer Institute
Bethesda, MD

Pankaj Gupta, M.D.
University of Minnesota
Minneapolis, MN

Brandy Heckman-Stoddard, Ph.D., M.P.H
National Cancer Institute
Bethesda, MD

Norah Lynn Henry, M.D., Ph.D., FASCO
University of Michigan
Ann Arbor, MI

Ryan T. Hughes, M.D.
Wake Forest University School of Medicine 
Winston-Salem, NC

Andrea I. Hutton
Patient Advocate  
Santa Barbara, CA

Sarah L. Kerns, Ph.D., M.P.H.
Medical College of Wisconsin 
Milwaukee, WI

Cecilia Lee, Dr.Ph., RN
National Cancer Institute
Bethesda, MD

Nancy Lenfestey, M.H.A.
Patient Advocate 
Cary, NC

Jennifer Le-Rademacher, Ph.D.
Mayo Clinic
Rochester, MN

Lisa Marie Lowenstein, Ph.D., M.P.H., R.D.
University of Texas MD Anderson Cancer Center
Houston, TX

Doug Midthune, M.S.
National Cancer Institute
Bethesda, MD

Karen Mustian, Ph.D., M.P.H. 
University of Rochester Medical Center
Rochester, NY

Luke Peppone, Ph.D.
University of Rochester Medical Center
Rochester, NY

Lev Sirota, Ph.D.
National Cancer Institute
Bethesda, MD

Micah A. Skeens, Ph.D., APRN, FAAN
Nationwide Children's Hospital 
Columbus, OH

Stephanie J. Sohl, Ph.D.
Wake Forest University School of Medicine
Winston-Salem, NC

Mylin A. Torres, MD
Emory University Winship Cancer Institute 
Atlanta, GA

Joseph M. Unger, Ph.D., M.S.
Fred Hutchinson Cancer Research Center
Seattle, WA

Lynne Wagner, Ph.D.
Wake Forest University School of Medicine
Winston-Salem, NC

Matthias Weiss, M.D.
ThedaCare Cancer Care
Appleton, WI

Jennifer A. Wenzel, Ph.D., M.S., RN
Johns Hopkins University
Baltimore, MD

Elizabeth Wulff-Burchfield, M.D.
University of Kansas Medical Center
Kansas City, KS

NCI CCCT Program Director (Interim)

Mehrdad Mohseni, M.D.
mehrdad.mohseni@nih.gov

 

  • Updated:
Email